Anna Minchom, MD, MRCP, MBBCh, The Royal Marsden NHS Foundation Trust, London, UK, notes what she is hoping to hear more on at the British Thoracic Oncology Group (BTOG) Annual Conference 2023 in Belfast, UK. In particular, she notes the optimizing of existing drugs, and the use of immunotherapy in poor-performance-status patients and those with oncogenic-driven cancers, as main areas of interest. This interview took place at the British Thoracic Oncology Group (BTOG) Annual Conference 2023 in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
